Optimizing the Readability and Clarity of an Academic Paper Paragraph on Breast Cancer Immunotherapy

Preliminary findings from the use of PD-1/PD-L1 antagonists indicate that specific types of breast cancers possess inherent immunogenicity, leading to sustained clinical responses in select patients. However, the effectiveness of monotherapy is restricted, observed in less than 10% of patients with metastatic disease. This study employed an intersection analysis to compare the expression of differentially expressed genes (DEGs) in tumor tissues of breast cancer (BC) patients and normal controls, utilizing data from The Cancer Genome Atlas (TCGA) database.